Get the Stockscreener App
1.06
6.65%
0.0661
After Hours:
1.07
0.01
+0.94%
Standard Biotools Inc stock is traded at $1.06, with a volume of 1.10M.
It is up +6.65% in the last 24 hours and up +0.00% over the past month.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
See More
Previous Close:
$0.9939
Open:
$1.01
24h Volume:
1.10M
Relative Volume:
0.80
Market Cap:
$364.85M
Revenue:
$106.34M
Net Income/Loss:
$-74.66M
P/E Ratio:
-1.1158
EPS:
-0.95
Net Cash Flow:
$-46.12M
1W Performance:
+4.95%
1M Performance:
+0.00%
6M Performance:
-41.76%
1Y Performance:
-57.94%
1-Day Range:
$1.001
$1.10
1-Week Range:
$0.9844
$1.10
52-Week Range:
$0.92
$2.50
Standard Biotools Inc Stock (LAB) Company Profile
Name
Standard Biotools Inc
Sector
Industry
Phone
(650) 266-6000
Address
2 TOWER PLACE, SOUTH SAN FRANCISCO
Compare LAB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
1.06 | 364.85M | 106.34M | -74.66M | -46.12M | -0.95 |
|
ABT
Abbott Laboratories
|
133.58 | 232.41B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.09 | 155.73B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
383.89 | 146.23B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.44 | 106.37B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.52 | 45.88B | 5.54B | 4.18B | 623.10M | 7.00 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-27-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-16-24 | Initiated | TD Cowen | Buy |
| Apr-04-24 | Initiated | Jefferies | Buy |
| Jul-12-23 | Initiated | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc Stock (LAB) Latest News
Standard BioTools Inc. (NASDAQ:LAB) Stake Cut by Nuveen Asset Management LLC - Defense World
Standard BioTools: Too Early To Determine The Fate Of This Turnaround (NASDAQ:LAB) - Seeking Alpha
ProShare Advisors LLC Buys 27,334 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
BNP Paribas Financial Markets Decreases Stake in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Jane Street Group LLC Has $414,000 Holdings in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools to Host Inaugural “Proteomics Roundtable” Webc - GuruFocus
Standard BioTools (LAB) Unveils Proteomics Roundtable Series | L - GuruFocus
Standard BioTools (LAB) Unveils Proteomics Roundtable Series | LAB Stock News - GuruFocus
Deutsche Bank AG Increases Holdings in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools to Host Inaugural 'Proteomics Roundtable” Webcast Series - The Manila Times
Standard BioTools to Host Inaugural “Proteomics Roundtable” Webcast Series - GlobeNewswire
Standard BioTools to host inaugural ‘Proteomics Roundtable’ series - TipRanks
Top Executive Sells Thousands of Standard BioTools Shares! - TipRanks
Standard biotools CEO Michael Egholm sells $5,150 in stock By Investing.com - Investing.com Canada
Standard biotools CEO Michael Egholm sells $5,150 in stock - Investing.com
Standard biotools CEO Michael Egholm sells $5,126 in stock By Investing.com - Investing.com Canada
Standard biotools CEO Michael Egholm sells $5,126 in stock - Investing.com India
Further weakness as Standard BioTools (NASDAQ:LAB) drops 15% this week, taking five-year losses to 79% - simplywall.st
Standard BioTools Inc. (NASDAQ:LAB) Stocks Pounded By 26% But Not Lagging Industry On Growth Or Pricing - simplywall.st
Standard biotools executive sells $25,784 in stock By Investing.com - Investing.com South Africa
Standard biotools executive sells $25,784 in stock - Investing.com India
Top Executive Offloads Thousands of Standard BioTools Shares! - TipRanks
Standard Biotools CEO Michael Egholm sells shares worth $4,860 - Investing.com Australia
Standard Biotools CEO Michael Egholm sells shares worth $4,860 By Investing.com - Investing.com India
Fluidigm stock plunges to 52-week low of $0.95 - Investing.com Australia
Fluidigm stock plunges to 52-week low of $0.95 By Investing.com - Investing.com Canada
Northern Trust Corp Has $5.03 Million Stock Position in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools Inc. (NASDAQ:LAB) Shares Sold by Dimensional Fund Advisors LP - Defense World
Price T Rowe Associates Inc. MD Buys 16,475 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference - marketscreener.com
Standard BioTools outlines $165M-$175M revenue target for FY2025 while driving proteomics partnerships - MSN
Before You Sell Standard BioTools Inc (NASDAQ: LAB) Shares, Here’sWhat You Need To Know. - Stocksregister
Standard BioTools First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
MetLife Investment Management LLC Purchases 40,057 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools Inc. Earnings Call: Mixed Outlook Amid Challenges - TipRanks
Standard BioTools Inc. (NASDAQ:LAB) Q1 2025 Earnings Call Transcript - Insider Monkey
Standard BioTools Inc (LAB) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... - Yahoo
Standard BioTools Inc (LAB) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Standard BioTools Inc (LAB) Q1 2025 Earnings Call Highlights: Na - GuruFocus
FLUIDIGM CORP : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K) - marketscreener.com
Standard BioTools: Q1 Earnings Snapshot - CTPost
Standard BioTools Shows Resilience Amid Revenue Decline - TipRanks
Standard BioTools Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:LAB) - Seeking Alpha
Earnings call transcript: Standard Biotools reports Q1 2025 loss, stock dips - Investing.com Nigeria
Standard BioTools (LAB) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Standard BioTools Q1 2025 Financial Results Overview - TipRanks
Standard BioTools Inc (LAB) Q1 2025 Earnings: EPS of -$0.07 Beats Estimate, Revenue of $40.8M Exceeds Expectations - GuruFocus
Standard Biotools Inc Stock (LAB) Financials Data
Revenue
Net Income
Cash Flow
EPS
Standard Biotools Inc Stock (LAB) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Mackay Sean | SVP & Chief Business Officer |
May 23 '25 |
Sale |
0.94 |
13,217 |
12,437 |
843,076 |
| Egholm Michael | President & CEO |
May 23 '25 |
Sale |
0.94 |
5,473 |
5,150 |
2,741,191 |
| Kim Hanjoon Alex | Chief Financial Officer |
May 22 '25 |
Sale |
1.00 |
1,355 |
1,358 |
931,714 |
| Egholm Michael | President & CEO |
May 22 '25 |
Sale |
1.00 |
5,116 |
5,126 |
2,746,664 |
| Mackay Sean | SVP & Chief Business Officer |
May 21 '25 |
Sale |
1.03 |
12,838 |
13,223 |
868,829 |
| Mackay Sean | SVP & Chief Business Officer |
May 22 '25 |
Sale |
1.00 |
12,536 |
12,561 |
856,293 |
0.56%
1.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):